Dexcom Inc’s recent filing unveils that its EVP, Chief HR Officer Stern Sadie unloaded Company’s shares for reported $32593.0 on Dec 16 ’24. In the deal valued at $76.87 per share,424 shares were sold. As a result of this transaction, Stern Sadie now holds 70,768 shares worth roughly $6.25 million.
Then, Sylvain Jereme M sold 744 shares, generating $57,191 in total proceeds. Upon selling the shares at $76.87, the EVP, Chief Financal Officer now owns 80,030 shares.
Before that, Leach Jacob Steven sold 744 shares. Dexcom Inc shares valued at $57,191 were divested by the EVP, Chief Operating Officer at a price of $76.87 per share. As a result of the transaction, Leach Jacob Steven now holds 264,171 shares, worth roughly $23.34 million.
Robert W. Baird upgraded its Dexcom Inc [DXCM] rating to an Outperform from a a Neutral in a research note published on January 16, 2025; the price target was increased to $104 from $86. A number of analysts have revised their coverage, including Robert W. Baird’s analysts, who decreased its forecast for the stock in late July from “an Outperform” to “a Neutral”. JP Morgan also remained covering DXCM and has decreased its forecast on July 26, 2024 with a “Neutral” recommendation from previously “an Overweight” rating. Redburn Atlantic started covering the stock on May 30, 2024. It rated DXCM as “a Neutral”.
Price Performance Review of DXCM
On Tuesday, Dexcom Inc [NASDAQ:DXCM] saw its stock jump 0.94% to $88.35. Over the last five days, the stock has gained 2.35%. Dexcom Inc shares have risen nearly 13.60% since the year began. Nevertheless, the stocks have fallen -30.16% over the past one year. While a 52-week high of $142.00 was reached on 01/27/25, a 52-week low of $62.34 was recorded on 01/13/25. SMA at 50 days reached $79.47, while 200 days put it at $91.32.
Levels Of Support And Resistance For DXCM Stock
The 24-hour chart illustrates a support level at 87.00, which if violated will result in even more drops to 85.65. On the upside, there is a resistance level at 89.35. A further resistance level may holdings at 90.35. The Relative Strength Index (RSI) on the 14-day chart is 67.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 4.53, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 7.76%. Stochastics %K at 92.85% indicates the stock is a selling.
How much short interest is there in Dexcom Inc?
A steep rise in short interest was recorded in Dexcom Inc stocks on 2025-01-15, dropping by -0.52 million shares to a total of 8.81 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 9.33 million shares. There was a decline of -5.93%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on March 12, 2024 when RBC Capital Mkts began covering the stock and recommended ‘”an Outperform”‘ rating along with a $165 price target.
